{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T02:29:19Z","timestamp":1791599359049,"version":"4.3.4"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002701","name":"Ministry of Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002701","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015063","name":"National Institute of Technology Calicut","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015063","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004507","name":"Central Drug Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004507","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["EEQ\/2020\/000303"],"award-info":[{"award-number":["EEQ\/2020\/000303"]}],"id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["IF190417"],"award-info":[{"award-number":["IF190417"]}],"id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["SR\/FIST\/CS-I\/2019\/120"],"award-info":[{"award-number":["SR\/FIST\/CS-I\/2019\/120"]}],"id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.bmcl.2025.130444","type":"journal-article","created":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T22:35:33Z","timestamp":1760826933000},"page":"130444","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Coumarin\u2013benzimidazole hybrids: Design, synthesis and identification of potential anticancer agents"],"prefix":"10.1016","volume":"131","author":[{"given":"C.G.","family":"Arya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neethu Mariam","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Munugala","family":"Chandrakanth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anoop","family":"Kallingal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.G.","family":"Amrutha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.S.","family":"Sivapriya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramesh","family":"Gondru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janardhan","family":"Banothu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bmcl.2025.130444_bb0005","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA A Cancer J Clin"},{"key":"10.1016\/j.bmcl.2025.130444_bb0010","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/s41571-023-00798-3","article-title":"The global burden of lung cancer: current status and future trends","volume":"20","author":"Leiter","year":"2023","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.bmcl.2025.130444_bb0015","article-title":"Advances of clinically approved small-molecule drugs for the treatment of non-small cell lung cancer","volume":"261","author":"Niu","year":"2023","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2025.130444_bb0020","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.891652","article-title":"Multidrug resistance in cancer: understanding molecular mechanisms, immunoprevention and therapeutic approaches","volume":"12","author":"Emran","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.bmcl.2025.130444_bb0025","unstructured":"NIH, National Cancer Institute, Side Effects of Cancer Treatment. https:\/\/www. cancer.gov\/about-cancer\/treatment\/side-effects."},{"key":"10.1016\/j.bmcl.2025.130444_bb0030","series-title":"Next Generation Kinase Inhibitors","author":"Shapiro","year":"2020"},{"issue":"33","key":"10.1016\/j.bmcl.2025.130444_bb0035","doi-asserted-by":"crossref","first-page":"13130","DOI":"10.1039\/D4SC01088D","article-title":"The prospect of substrate-based kinase inhibitors to improve target selectivity and overcome drug resistance","volume":"15","author":"Biswas","year":"2024","journal-title":"Chem Sci"},{"key":"10.1016\/j.bmcl.2025.130444_bb0040","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1021\/acs.jmedchem.1c00963","article-title":"Small molecule kinase inhibitor drugs (1995-2021): medical indication, pharmacology, and synthesis","volume":"65","author":"Ayala-aguilera","year":"2022","journal-title":"J Med Chem"},{"issue":"1","key":"10.1016\/j.bmcl.2025.130444_bb0045","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3390\/scipharm93010006","article-title":"Targeting c-MYC G-quadruplexes for cancer treatment with small molecules","volume":"93","author":"Thumpati","year":"2025","journal-title":"Sci Pharm"},{"issue":"3","key":"10.1016\/j.bmcl.2025.130444_bb0050","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1021\/acsmedchemlett.3c00537","article-title":"Selective recognition of c-KIT 1 G-Quadruplex by structural tuning of heteroaromatic scaffolds and side chains","volume":"15","author":"Fatma","year":"2024","journal-title":"ACS Med Chem Lett"},{"issue":"2","key":"10.1016\/j.bmcl.2025.130444_bb0055","doi-asserted-by":"crossref","first-page":"ugae005","DOI":"10.1093\/narmme\/ugae005","article-title":"Combating multidrug-resistance in S. pneumoniae: a G-quadruplex binding inhibitor of efflux pump and its bio-orthogonal assembly","volume":"1","author":"Chaudhuri","year":"2024","journal-title":"NAR Mol Med"},{"issue":"2","key":"10.1016\/j.bmcl.2025.130444_bb0060","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.apsb.2022.09.010","article-title":"Benzimidazole and its derivatives as cancer therapeutics: the potential role from traditional to precision medicine","volume":"13","author":"Lee","year":"2023","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.bmcl.2025.130444_bb0065","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.762807","article-title":"A comprehensive account on recent Progress in pharmacological activities of Benzimidazole derivatives","volume":"12","author":"Brishty","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.bmcl.2025.130444_bb0070","doi-asserted-by":"crossref","first-page":"6045","DOI":"10.1021\/acs.jmedchem.7b00108","article-title":"Triaryl Benzimidazoles as a new class of antibacterial agents against resistant pathogenic microorganisms","volume":"60","author":"Picconi","year":"2017","journal-title":"J Med Chem"},{"issue":"7","key":"10.1016\/j.bmcl.2025.130444_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2020.115403","article-title":"Novel class of benzimidazole-thiazole hybrids: the privileged scaffolds of potent anti-inflammatory activity with dual inhibition of cyclooxygenase and 15-lipoxygenase enzymes","volume":"28","author":"Maghraby","year":"2020","journal-title":"Bioorg Med Chem"},{"issue":"10","key":"10.1016\/j.bmcl.2025.130444_bb0080","doi-asserted-by":"crossref","first-page":"7571","DOI":"10.1039\/D4RA08864F","article-title":"Benzimidazole(s): synthons, bioactive lead structures, total synthesis, and the profiling of major bioactive categories","volume":"15","author":"Aroua","year":"2025","journal-title":"RSC Adv"},{"key":"10.1016\/j.bmcl.2025.130444_bb0085","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.201700040","article-title":"Benzimidazole scaffold as anticancer agent: synthetic approaches and structure-activity relationship","volume":"350","author":"Shrivastava","year":"2017","journal-title":"Arch Pharm (Weinheim)"},{"key":"10.1016\/j.bmcl.2025.130444_bb0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/cmdc.202100004","article-title":"Benzimidazoles in drug discovery: a patent review","volume":"16","author":"Law","year":"2021","journal-title":"ChemMedChem"},{"issue":"7","key":"10.1016\/j.bmcl.2025.130444_bb0095","doi-asserted-by":"crossref","first-page":"663","DOI":"10.3390\/ph14070663","article-title":"Structure-activity relationship analysis of Benzimidazoles as emerging anti-inflammatory agents: an overview","volume":"14","author":"Veerasamy","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.bmcl.2025.130444_bb0100","doi-asserted-by":"crossref","first-page":"1105175","DOI":"10.1016\/j.bioorg.2021.105175","article-title":"Benzimidazole analogues as efficient arsenals in war against methicillin-resistance staphylococcus aureus (MRSA) and its SAR studies","volume":"115","author":"Zha","year":"2021","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmcl.2025.130444_bb0105","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s00044-021-02824-4","article-title":"Drug repositioning of benzimidazole anthelmintics in the treatment of cryptococcosis: a review","volume":"31","author":"Oliveira","year":"2022","journal-title":"Med Chem Res"},{"key":"10.1016\/j.bmcl.2025.130444_bb0110","doi-asserted-by":"crossref","first-page":"3667","DOI":"10.1016\/j.bmcl.2012.12.071","article-title":"Synthesis of new conjugated coumarin-benzimidazole hybrids and their anticancer activity","volume":"23","author":"Paul","year":"2013","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmcl.2025.130444_bb0115","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.ejmech.2013.02.008","article-title":"Coumarins hinged directly on benzimidazoles and their ribofuranosides to inhibit hepatitis C virus","volume":"63","author":"Tsay","year":"2013","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2025.130444_bb0120","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1021\/jm801240d","article-title":"Structure-activity relationship of new anti-hepatitis C virus agents: heterobicycle-coumarin conjugates","volume":"52","author":"Neyts","year":"2009","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2025.130444_bb0125","doi-asserted-by":"crossref","first-page":"4709","DOI":"10.1016\/j.bmcl.2016.08.045","article-title":"One pot click chemistry: a three component reaction for the synthesis of 2-mercaptobenzimidazole linked coumarinyl triazoles as anti-tubercular agents","volume":"26","author":"Anand","year":"2016","journal-title":"Bioorg Med ChemLett"},{"key":"10.1016\/j.bmcl.2025.130444_bb0130","doi-asserted-by":"crossref","first-page":"760","DOI":"10.3109\/14756366.2015.1063624","article-title":"Coumarin or benzoxazinone based novel carbonic anhydrase inhibitors: synthesis, molecular docking and anticonvulsant studies","volume":"31","author":"Karatas","year":"2016","journal-title":"Enzym Inhib Med Chem"},{"key":"10.1016\/j.bmcl.2025.130444_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.fitote.2021.104863","article-title":"Coumarin-based derivatives with potential anti-HIV activity","volume":"150","author":"Xu","year":"2021","journal-title":"Fitoterapia"},{"issue":"1","key":"10.1016\/j.bmcl.2025.130444_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2020.e03217","article-title":"Coumarin: an emerging antiviral agent","volume":"6","author":"Mishra","year":"2020","journal-title":"Heliyon"},{"key":"10.1016\/j.bmcl.2025.130444_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104163","article-title":"Recent advancements of coumarin-based anticancer agents: an up-to-date review","volume":"103","author":"Al-Warhi","year":"2020","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmcl.2025.130444_bb0150","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.1016\/j.bmc.2019.06.033","article-title":"Rational approaches, design strategies, structure activity relationship and mechanistic insights for therapeutic coumarin hybrids","volume":"27","author":"Singh","year":"2019","journal-title":"Bioorg Med Chem"},{"issue":"2","key":"10.1016\/j.bmcl.2025.130444_bb0155","doi-asserted-by":"crossref","first-page":"250","DOI":"10.3390\/molecules23020250","article-title":"Coumarin: a natural, privileged and versatile scaffold for bioactive compounds","volume":"23","author":"Stefanachi","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.bmcl.2025.130444_bb0160","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1097\/CAD.0000000000000232","article-title":"Derivatives containing both coumarin and benzimidazole potently induce caspase-dependent apoptosis of cancer cells through inhibition of PI3K-AKT-mTOR signaling","volume":"26","author":"Liu","year":"2015","journal-title":"Anti-Cancer Drugs"},{"issue":"3","key":"10.1016\/j.bmcl.2025.130444_bb0165","doi-asserted-by":"crossref","first-page":"541","DOI":"10.4314\/bcse.v32i3.13","article-title":"The uses of ethyl 2-(1H-benzo[D]imidazol-2-yl)acetate to synthesis pyrazole, thiophene, pyridine and coumarin derivatives with antitumor activities","volume":"32","author":"Mohareb","year":"2018","journal-title":"Bull Chem Soc Ethiop"},{"key":"10.1016\/j.bmcl.2025.130444_bb0170","article-title":"Coumarin-benzimidazole hybrids: a review of developments in medicinal chemistry","volume":"227","author":"Arya","year":"2022","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2025.130444_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2024.129881","article-title":"Identification of coumarin - benzimidazole hybrids as potential antibacterial agents: synthesis, in vitro and in vivo biological assessment, and ADMET prediction","volume":"110","author":"Arya","year":"2024","journal-title":"Bioorg Med Chem Lett"},{"issue":"9","key":"10.1016\/j.bmcl.2025.130444_bb0180","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1021\/acssuschemeng.5b00826","article-title":"Room temperature one-pot green synthesis of Coumarin-3-carboxylic acids in water: a practical method for the large-scale synthesis","volume":"3","author":"Brahmachari","year":"2015","journal-title":"ACS Sustain Chem Eng"},{"key":"10.1016\/j.bmcl.2025.130444_bb0185","doi-asserted-by":"crossref","first-page":"100631","DOI":"10.1016\/j.rechem.2022.100631","article-title":"Coumarin \u2013 benzimidazole hybrids: a review on diverse synthetic strategies","volume":"4","author":"Arya","year":"2022","journal-title":"Results Chem"},{"key":"10.1016\/j.bmcl.2025.130444_bb0190","series-title":"Cancer Cell Culture","first-page":"237","article-title":"Cell sensitivity assays: The MTT assay","volume":"Vol. 731","author":"Meerloo","year":"2011"},{"key":"10.1016\/j.bmcl.2025.130444_bb0195","doi-asserted-by":"crossref","first-page":"8038","DOI":"10.1039\/D4NJ00824C","article-title":"Novel fused pyran derivatives induce apoptosis and target cell cycle progression in anticancer efficacy against multiple cell lines","volume":"48","author":"Fabitha","year":"2024","journal-title":"New J Chem"},{"key":"10.1016\/j.bmcl.2025.130444_bb0200","doi-asserted-by":"crossref","first-page":"3671","DOI":"10.1039\/D5MD00161G","article-title":"Improved anti-breast cancer activity through structural modification of fused pyran derivatives and mechanistic investigations","volume":"16","author":"Fabitha","year":"2025","journal-title":"RSC Med Chem"},{"key":"10.1016\/j.bmcl.2025.130444_bb0205","article-title":"2-substituted and 1,2-disubstitued benzimidazole derivatives: synthesis and identification of potential antibacterial agents","volume":"1333","author":"Arya","year":"2025","journal-title":"J Mol Struct"},{"key":"10.1016\/j.bmcl.2025.130444_bb0210","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.ejmech.2014.10.001","article-title":"PASS-assisted design, synthesis and antioxidant evaluation of new butylated hydroxytoluene derivatives","volume":"87","author":"Ariffin","year":"2014","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2025.130444_bb0215","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1186\/1472-6882-13-343","article-title":"PASS-predicted Vitex negundo activity: antioxidant and antiproliferative properties on human hepatoma cells--an in vitro study","volume":"13","author":"Kadir","year":"2013","journal-title":"BMC Complement Altern Med"},{"issue":"13","key":"10.1016\/j.bmcl.2025.130444_bb0220","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1016\/j.bmcl.2014.04.079","article-title":"Synthesis and in vitro antiproliferative evaluation of novel N-alkylated 6-isobutyl- and propyl pyrimidine derivatives","volume":"24","author":"Gazivoda Kraljevi\u0107","year":"2014","journal-title":"Bioorg Med Chem Lett"},{"issue":"34","key":"10.1016\/j.bmcl.2025.130444_bb0225","doi-asserted-by":"crossref","first-page":"21550","DOI":"10.1021\/acsomega.0c02165","article-title":"Discovery of Harmaline as a potent inhibitor of sphingosine Kinase-1: a Chemopreventive role in lung Cancer","volume":"5","author":"Roy","year":"2020","journal-title":"ACS Omega"},{"key":"10.1016\/j.bmcl.2025.130444_bb0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fonc.2020.00289","article-title":"Sphingosine kinase 1 in breast Cancer-a new molecular marker and a therapy target","volume":"10","author":"Alshaker","year":"2020","journal-title":"Front Oncol"},{"issue":"9","key":"10.1016\/j.bmcl.2025.130444_bb0235","doi-asserted-by":"crossref","first-page":"4233","DOI":"10.1021\/acs.jmedchem.8b01469","article-title":"Cyclin-dependent kinase 2 inhibitors in Cancer therapy: an update","volume":"62","author":"Tadesse","year":"2019","journal-title":"J Med Chem"},{"issue":"3","key":"10.1016\/j.bmcl.2025.130444_bb0240","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/nrd1032","article-title":"ADMET in silico modelling: towards prediction paradise?","volume":"2","author":"Waterbeemd","year":"2003","journal-title":"Nat Rev Drug Discov"},{"issue":"7","key":"10.1016\/j.bmcl.2025.130444_bb0245","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/nrd4609","article-title":"An analysis of the attrition of drug candidates from four major pharmaceutical companies","volume":"14","author":"Waring","year":"2015","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.bmcl.2025.130444_bb0250","series-title":"An investigation into the use of computational and in vitro methods for acute systemic toxicity prediction","isbn-type":"print","author":"Norlen","year":"2012","ISBN":"https:\/\/id.crossref.org\/isbn\/9789279217081"}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X25003531?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X25003531?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T10:35:07Z","timestamp":1780914907000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X25003531"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":50,"alternative-id":["S0960894X25003531"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2025.130444","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Coumarin\u2013benzimidazole hybrids: Design, synthesis and identification of potential anticancer agents","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2025.130444","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"130444"}}